These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 30462621)
1. Neuromuscular blocking agents for adult patients with acute respiratory distress syndrome: A meta-analysis of randomized controlled trials. Tao W; Yang LQ; Gao J; Shao J J Trauma Acute Care Surg; 2018 Dec; 85(6):1102-1109. PubMed ID: 30462621 [TBL] [Abstract][Full Text] [Related]
2. Neuromuscular blockers in the acute respiratory distress syndrome: A meta-analysis. Hua Y; Ou X; Li Q; Zhu T PLoS One; 2020; 15(1):e0227664. PubMed ID: 31961896 [TBL] [Abstract][Full Text] [Related]
4. The effect of neuromuscular blocking agents uses in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Lyu T; Lee YS; Dhanvijay S; Freebairn R Minerva Anestesiol; 2021 Mar; 87(3):341-350. PubMed ID: 33300324 [TBL] [Abstract][Full Text] [Related]
5. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials. Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488 [TBL] [Abstract][Full Text] [Related]
6. Early neuromuscular blocking agents for adults with acute respiratory distress syndrome: a systematic review, meta-analysis and meta-regression. Shao S; Kang H; Tong Z BMJ Open; 2020 Nov; 10(11):e037737. PubMed ID: 33444180 [TBL] [Abstract][Full Text] [Related]
7. Paralytics in critical care: not always the bad guy. Forel JM; Roch A; Papazian L Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410 [TBL] [Abstract][Full Text] [Related]
8. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Arroliga AC; Thompson BT; Ancukiewicz M; Gonzales JP; Guntupalli KK; Park PK; Wiedemann HP; Anzueto A; Crit Care Med; 2008 Apr; 36(4):1083-8. PubMed ID: 18401254 [TBL] [Abstract][Full Text] [Related]
9. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome. Mefford B; Donaldson JC; Bissell BD Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121 [No Abstract] [Full Text] [Related]
10. The role of neuromuscular blockers in ARDS: benefits and risks. Hraiech S; Forel JM; Papazian L Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207 [TBL] [Abstract][Full Text] [Related]
11. [The effect of neuromuscular blocking agents on prognosis of patients with acute respiratory distress syndrome: a meta analysis]. Wang AT; Gao JL; Li XL; Leng YX; Yao ZY; Zhu X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Mar; 25(3):149-53. PubMed ID: 23656767 [TBL] [Abstract][Full Text] [Related]
12. Neuromuscular Blocking Agents for ARDS: A Systematic Review and Meta-Analysis. Torbic H; Krishnan S; Harnegie MP; Duggal A Respir Care; 2021 Jan; 66(1):120-128. PubMed ID: 32843506 [TBL] [Abstract][Full Text] [Related]
13. Lung Recruitment Maneuvers for Adult Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis. Goligher EC; Hodgson CL; Adhikari NKJ; Meade MO; Wunsch H; Uleryk E; Gajic O; Amato MPB; Ferguson ND; Rubenfeld GD; Fan E Ann Am Thorac Soc; 2017 Oct; 14(Supplement_4):S304-S311. PubMed ID: 29043837 [TBL] [Abstract][Full Text] [Related]
14. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. Fan E; Brodie D; Slutsky AS JAMA; 2018 Feb; 319(7):698-710. PubMed ID: 29466596 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome]. Lyu G; Wang X; Jiang W; Cai T; Zhang Y Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261 [TBL] [Abstract][Full Text] [Related]
16. Paediatric Acute Respiratory Distress Syndrome Neuromuscular Blockade study (PAN-study): a phase IV randomised controlled trial of early neuromuscular blockade in moderate-to-severe paediatric acute respiratory distress syndrome. Rudolph MW; Slager S; Burgerhof JGM; van Woensel JBM; Alffenaar JC; Wösten-van Asperen RM; de Hoog M; IJland MM; Kneyber MCJ; Trials; 2022 Jan; 23(1):96. PubMed ID: 35101098 [TBL] [Abstract][Full Text] [Related]
17. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey. Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426 [TBL] [Abstract][Full Text] [Related]
18. [A meta-analysis of the effect of neuromuscular blocking agents on oxygenation in patients with acute respiratory distress syndrome]. Gao ZW; Li C; Chen H; Xie JF; Liu L; Yang Y Zhonghua Nei Ke Za Zhi; 2022 Jan; 61(1):86-94. PubMed ID: 34979776 [No Abstract] [Full Text] [Related]
19. The use of paralytics in patients with acute respiratory distress syndrome. Hraiech S; Dizier S; Papazian L Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423 [TBL] [Abstract][Full Text] [Related]
20. High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome. Sud S; Sud M; Friedrich JO; Wunsch H; Meade MO; Ferguson ND; Adhikari NK Cochrane Database Syst Rev; 2013 Feb; (2):CD004085. PubMed ID: 23450549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]